Bacterial expression of bowman-birk protease inhibitors and...

Details Bacterial expression of bowman-birk protease inhibitors and... Bacterial expression of bowman-birk protease inhibitors and...

2004-11-08

2008-08-19

Tsang, Cecilia (Department: 1654)

Chemistry: molecular biology and microbiology

Micro-organism, tissue cell culture or enzyme using process...

Using a micro-organism to make a protein or polypeptide

C435S252300, C435S252310, C536S023100

Reexamination Certificate

active

07413877

ABSTRACT:
The present invention provides compositions and methods related to the expression of Bowman-Birk protease inhibitors and variants thereof in bacterial species. The present invention further provides fusion nucleic acids, vectors, fusion polypeptides, and processes for obtaining the Bowman-Birk protease inhibitors.

REFERENCES:
patent: 5411873 (1995-05-01), Adams et al.
patent: 5429950 (1995-07-01), Power et al.
patent: 5679543 (1997-10-01), Lawlis
patent: 6063611 (2000-05-01), Van Solingen
patent: 6537968 (2003-03-01), Lezdey et al.
patent: 6872563 (2005-03-01), Beckwith et al.
patent: WO 88/02025 (1987-08-01), None
patent: WO 00/05406 (2000-02-01), None
Flecker “Chemical synthesis, molecular cloning and expression of gene coding for a Bowman-Birk-type proteinase inhibitor,” Eur. J. Biochem., 1987, 166, 151-6.
Billings et al., “A Growth-regulated Protease Activity that is Inhibited by the Anticarcinogenic Bowman-Birk Protease Inhibitor,”Proc. Natl. Acad. Sci. USA, 89:3120-3124 (1992).
Birk, “The Bowman-Birk Inhibitor. Trypsin- and Chymotrypsin-inhibitor from Soybeans,”Int. J. Peptide Protein Res., 25:113-131 (1985).
Bode et al., “Natural Protein Proteinase Inhibitors and Their Interaction with Proteinases,”Eur. J. Biochem., 204:433-451 (1992).
Chen et al., “Reactive Sites of an Anticarcinogenic Bowman-Birk Proteinase Inhibitor are Similar to Other Trypsin Inhibitors,”The Journal of Biological Chemistry, 267(3):1990-1994 (1992).
Christmann et al., “The Cystine Knot of a Squash-type Protease Inhibitor as a Structural Scaffold forEscherichia coliCell Surface Display of Conformationally Constrained Peptides,”Protein Engineering, 12(9):797-806 (1999).
Ferrari et al., “Transcription ofBacillus subtilisSubtilisin and Expression of Subtilisin in Sporulation Mutants,”Journal of Bacteriology, 170(1):289-295 (1988).
Flecker et al., “Chemical Synthesis, Molecular Cloning and Expression of Gene Coding for a Bowman-Birk-type Proteinase Inhibitor,”Eur. J. Biochem., 166:151-156 (1987).
Hahn et al., “Regulatory Inputs for the Synthesis of ComK, the Competence Transcription Factor ofBacillus subtilis,” Molecular Microbiology, 21(4):763-775 (1996).
Henner et al., “Location of the Targets of thehpr-97, sacU32(Hy), andsacQ36(Hy) Mutations in Upstream Regions of the Subtilisin Promoter,”J. Bact., 170(1):296-300 (1988).
Hengen “Purification of His-Tag Fusion Proteins fromEscherichia coli,” TIBS, 20:285-286 (1995).
Kajino et al., “A Protein Disulfide Isomerase Gene Fusion Expression System that Increases the Extracellular Productivity ofBacillus brevis,” Applied and Environmental Microbiology, 66(2):638:642 (2000).
Kemperman et al., “Identification and Characterization of Two Novel Clostridial Bacteriocins, Circularin A and Closticin 574,”Applied and Environmental Microbiology, 69(3):1589-1597 (2003).
Kennedy “The Bowman-Birk Inhibitor from Soybeans as an Anticarcinogenic Agent,”Am. J. Clin. Nutr., 68:1406S-12S (1998).
Landon,Methods in Enzymology, Cleavage at Aspartyl-Prolyl Bonds, Academic Press, Inc., pp. 145-149 (1977).
Lidell et al., “An Autocatalytic Cleavage in the C Terminus of the Human MUC2 Mucin Occurs at the Low pH of the Late Secretory Pathway,”The Journal of Biological Chemistry, 278(16):13944-13951 (2003).
Lin et al., “The 0.25-nm X-ray Structure of the Bowman-Birk-type Inhibitor from Mung Bean in Ternary Complex with Porcine Trypsin,”Eur. J. Biochem., 212:549-555 (1993).
Liu,Soybeans, Chemistry, Technology and Utilization, pp. 32-35, Aspen Publishers, Inc., Gaithersburg, Maryland (1999).
Meima et al., “ThebdbDCOperon ofBacillus subtilisEncodes Thiol-disulfide Oxidoreductases Required for Competence Developement,”The Journal of Biological Chemistry, 277(9):6994-7001 (2002).
Neidhardt et al., “Culture Medium for Enterobacteria,”Journal of Bacteriology, 119(3):736-747 (1974).
Odani et al., “Studies on Soybean Tryspin Inhibitors. IV. Complete Amino Acid Sequence and the Anti-proteinase Sites of Bowman-Birk Soybean Proteinase Inhibitor,”J. Biochem., 71:839-848 (1972).
Paine et al., “An Alternative Approach to Depigmentation by Soybean Extracts via Inhibition of the PAR-2 Pathway,”J. Invest. Dermatol., 116-587-595 (2001).
Perego, “Integrational Vectors for Genetic Manipulation inBacillus subtilis,” Bacillus subtilisand Other Gram-Positive Bacteria: Biochemistry, Physiology, and Molecular Genetics, Sonenshein, Hoch and Losick (eds.)American Society for Microbiology, Washington D.C., pp. 615-624 (1993).
Sahu et al., “Inhibition of Human Complement by a C3-Binding Peptide Isolated from a Phage-Displayed Random Peptide Library,”The Journal of Immunology, 157:884-891 (1996).
Seeboth et al., “In-vitro Cleavage of a Fusion Protein Bound to Cellulose Using the Soluble yscFs (Kex2) Variant,”Appl. Microbiol. Biotechnol., 37:621-625 (1992).
Ségalas et al., “A Particularly Labile Asp-Pro Bond in the Green Mamba Muscarinic Toxin MTX2. Effect of Protein Conformation on the Rate of Cleavage,”FEBS Letters, 371:171-175 (1995).
Shaw et al., “A Novel Combination of Two Classic Catalytic Schemes,”J. Mol. Biol., 320:303-309 (2002).
Song et al, “Kunitz-type Soybean Trypsin Inhibitor Revisited: Refined Structure of its Complex with Porcine Trypsin Reveals an Insight into the Interaction Between a Homologous Inhibitor fromErythrina caffraand Tissue-type Plasminogen Activator,”J. Mol. Biol., 275:347-363 (1998).
Van Tilbeurgh et al., “Fluorogenic and Chromogenic Glycosidases as Substrates and Ligands of Carbohydrases,”Methods in Enzymology, Academic Press, Inc., pp. 45-59 (1988).
Voss et al., “Crystal Structure of the Bifunctional Soybean Bowman-Birk Inhibitor at 0.28-nm Resolution,”Eur. J. Biochem., 242:122-131 (1996).
Werner et al., “Three-Dimensional Structure of Soybean Trypsin/Chymotrypsin Bowman-Birk Inhibitor in Solution,”Biochemistry, 31:999-1010 (1992).
Wolfson et al., “Modularity of Protein Function : Chimeric Interleukin 1βs Containing Specific Protease Inhibitor Loops Retain Function of Both Molecules,”Biochemistry, 32:5327-5331 (1993).

Affiliated with

Also associated with

Rating

Bacterial expression of bowman-birk protease inhibitors and... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Bacterial expression of bowman-birk protease inhibitors and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bacterial expression of bowman-birk protease inhibitors and... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4010418